Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 1.6
-5.88 %
$ 315 M
Market Cap
-2.39
P/E
ESPR - TOTAL LIABILITIES
Total Liabilities ESPR - Esperion Therapeutics, Inc.
661 M
LAST VALUE
6.87%
2 YEAR CAGR
59.34%
5 YEAR CAGR
65.83%
10 YEAR CAGR